BioSteel’s Cautionary Tale – Sponsorships Alone Can’t Save a Struggling Brand
The unfolding financial saga of sports drink maker BioSteel reveals some harsh lessons about betting big on star-studded sponsorships while failing to achieve actual viability as a business. Despite inking endorsements with the NHL, NBA, NFL and more, BioSteel is drowning in debt. Turns out, celebrity co-signs alone can’t rescue an operation lacking fundamentals like profitability and fiscal discipline.
BioSteel’s woes spotlight the hubris of growth-at-all-costs startups who think flashy partnerships can substitute for sound business practices. Too often, hot shot entrepreneurs chase vanity metrics like funding rounds raised or big-name endorsers signed. But those deals don’t magically equal dollars in the bank or forgive mismanagement of finances.
BioSteel’s trajectory offers a warning for other aspiring disrupters intoxicated by their own hype. No business can survive by promotions alone. Let’s examine the key takeaways from BioSteel’s stumbles any executives obsessed with shortcuts to success should heed.
Sponsorships Don’t Equal Profits
Like many overnight sensations, BioSteel exhibited the classic mistake of mistaking publicity for profitability. Yes, they scored major coups landing sponsorships with hockey, basketball, baseball and more. But they failed to actually convert those wins into revenues exceeding their ballooning costs. Inking a “dream partnership” means zilch if it’s not driving growth and cash flow.
Maybe it’s human nature to assume that if an NHL team plasters your logo everywhere, riches must follow. But brand awareness doesn’t automatically produce sales. And more importantly, it certainly doesn’t forgive reckless spending and lack of budget discipline. BioSteel behaved like they hit the jackpot with every new endorsement. In reality, they only dug a deeper hole betting these deals would single-handedly deliver success.
Scrimp on Substance, Not Promotion
Many flawed startups blow their limited capital on building hype rather than a quality product. Again, BioSteel exhibits this sin. They must have shelled out millions securing all those sports deals and athlete ambassadors. Yet apparently they invested far less in the unglamorous work to hone their product, streamline operations, and develop an actual path to profitability.
BioSteel wanted to be a real business without doing real business. Building substantive infrastructure is tedious work lacking the allure of big branding wins. But any company only concerned with marketing theatrics while ignoring nuts and bolts functions is doomed. If you divert resources from quality control, supply chain management, staffing and other subsurface duties to fund flashy promotions, don’t be surprised when it backfires.
Unit Economics Matter More Than Funding Rounds
Silicon Valley breeds startups focused on raising capital rather than revenue. The prevailing metric becomes how much funding you’ve secured, not boring metrics like per-unit costs. BioSteel exhibits shades of this distorted perspective. Sponsors and investors provided cash injections. But Covering basic operating expenses through steady sales seemed an afterthought.
Effective entrepreneurs don’t ask “How much money have I raised?” They ask “How much profit will I generate off each product sold?” That unit economic question reflects the financial viability of a business model, while funding raised just represents its short-term potential. BioSteel was seduced by hype and assumed more money could sustain them indefinitely. In reality, unit economics make or break startups.
No Business Runs on Branding Alone
Branding and sponsorships matter. But only when supporting an already robust business. BioSteel got the sequence backwards by leaning on them before nailing operational fundamentals. When branding outpaces substance, disaster follows.
Look at many failed startups in fields like electric vehicles. Their leaders were media darlings who seduced investors with lofty visions but never delivered. Theranos reached a $9 billion valuation on claims of revolutionary blood testing before being exposed as a sham. Even if ideas are brilliant, flashy branding can’t compensate for lousy execution. For startups, publicity supports success – it doesn’t create it.
BioSteel hopefully emerges wiser and committed to blocking and tackling business-building. We wish them well. But their woes stand as a warning on staking a company’s fate to celebrity co-signs. Mad Men mid-century ad man Don Draper had it right: “Advertising is based on one thing: happiness. And do you know what happiness is? Happiness is the smell of a new car. It’s freedom from fear. It’s a billboard on the side of a road that screams with reassurance that whatever you’re doing is OK.” Promotions provide reassurance, but operations deliver results. Never get the two confused.